Cannara Biotech Inc.

TSXV:LOVE.V

Sector

🛒 Consumer Staples

Industries

🚬 Tobacco

🍻 Alcoholic Beverages

🥖 Bread & Bakery

💄 Cosmetics

💊 Drugstores & Retail Pharmacies

🌹 Perfumes & Fragrances

🧴 Personal Care

Location

Canada

Market Cap

USD 87.83 M

Share Price

USD 0.96

Avg Daily Volume

43,371

Change (1 day)

-0.21%

Change (1 year)

Change (YTD)

67.67%

Cannara Biotech Inc. Enterprise Value to EBITDA (EV/EBITDA) on June 20, 2025: 10.57

Cannara Biotech Inc. Enterprise Value to EBITDA (EV/EBITDA) is 10.57 on June 20, 2025. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.

Cannara Biotech Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 11.20 on June 20, 2025, which is 6.03% above the current Enterprise Value to EBITDA (EV/EBITDA).
Cannara Biotech Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 7.43 on June 20, 2025, which is -29.71% below the current Enterprise Value to EBITDA (EV/EBITDA).
Cannara Biotech Inc. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 9.95.

Daily

From:

To:

Zoom:

Key data

Date	Enterprise Value to EBITDA (EV/EBITDA)	Free Cash Flow Yield	Dividend Yield	Market Capitalization

TSXV: LOVE.V

Cannara Biotech Inc.

CEO	Mr. Zohar Krivorot
IPO Date	Jan. 14, 2019
Location	Canada
Headquarters	333 Decarie Blvd.
Employees	461
Sector	🛒 Consumer Staples
Industries Tobacco 🍻 Alcoholic Beverages 🥖 Bread & Bakery 💄 Cosmetics 💊 Drugstores & Retail Pharmacies 🌹 Perfumes & Fragrances 🧴 Personal Care

Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.